Soligenix Inc (SNGX)
0.4045
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.3992
-0.01
(-1.31%)
Pre-Market: 20:00
Soligenix Net Income (Quarterly): -1.820M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.820M |
| September 30, 2023 | -1.663M |
| June 30, 2023 | -1.612M |
| March 31, 2023 | -1.046M |
| December 31, 2022 | -3.754M |
| September 30, 2022 | -3.309M |
| June 30, 2022 | -2.387M |
| March 31, 2022 | -4.349M |
| December 31, 2021 | -4.704M |
| September 30, 2021 | -3.588M |
| June 30, 2021 | -1.897M |
| March 31, 2021 | -2.362M |
| December 31, 2020 | -5.540M |
| September 30, 2020 | -1.790M |
| June 30, 2020 | -2.777M |
| March 31, 2020 | -7.581M |
| December 31, 2019 | -2.872M |
| September 30, 2019 | -2.721M |
| June 30, 2019 | -2.124M |
| March 31, 2019 | -1.640M |
| December 31, 2018 | -3.105M |
| September 30, 2018 | -1.862M |
| June 30, 2018 | -1.556M |
| March 31, 2018 | -2.377M |
| December 31, 2017 | -2.139M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.9631M |
| June 30, 2017 | -2.312M |
| March 31, 2017 | -1.733M |
| December 31, 2016 | -0.33M |
| September 30, 2016 | -1.673M |
| June 30, 2016 | -0.0928M |
| March 31, 2016 | -1.149M |
| December 31, 2015 | -2.059M |
| September 30, 2015 | 2.774M |
| June 30, 2015 | -3.978M |
| March 31, 2015 | -4.569M |
| December 31, 2014 | 1.923M |
| September 30, 2014 | -4.350M |
| June 30, 2014 | -0.9485M |
| March 31, 2014 | -3.332M |
| December 31, 2013 | 0.9934M |
| September 30, 2013 | -6.560M |
| June 30, 2013 | -3.405M |
| March 31, 2013 | -1.087M |
| December 31, 2012 | -0.9854M |
| September 30, 2012 | -0.759M |
| June 30, 2012 | -0.9799M |
| March 31, 2012 | -1.439M |
| December 31, 2011 | -0.9317M |
| September 30, 2011 | 2.205M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-7.581M
Minimum
Mar 2020
-1.046M
Maximum
Mar 2023
-3.047M
Average
-2.721M
Median
Sep 2019
Net Income (Quarterly) Benchmarks
| Eagle Pharmaceuticals Inc | 5.164M |
| Marinus Pharmaceuticals Inc | -41.77M |
| NovaBay Pharmaceuticals Inc | -4.108M |
| Palatin Technologies Inc | -7.844M |
| iBio Inc | -8.211M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.132M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | -0.9281M |
| Earnings Yield | -222.5% |
| Normalized Earnings Yield | -1183.80 |